Sai Silks (Kalamandir) Limited (KALAMANDIR) Stock Analysis | TradeA…

GLAND2 months ago

Gland Pharma Limited (gland) Gets Approval for Sugammadex Injection 200 Mg/2 ML

Gland Pharma Limited (GLAND) receives USFDA approval for Sugammadex Injection 200 mg/2 mL, expanding its injectable portfolio.
Drug Manufacturers - Specialty and Generic2 months ago

Gland Pharma Limited (NSE: GLAND) breaks below support, falls 5%

Gland Pharma Limited (NSE: GLAND) stock price dropped 5% intraday to ₹2353.7, breaking below support in the Healthcare sector.
Drug Manufacturers - Specialty and Generic3 months ago

Gland Pharma Limited (GLAND) gains 5% intraday, tests resistance

Gland Pharma Limited (NSE: GLAND) moves up 5% intraday to ₹2502.1, testing resistance in the healthcare sector. Check the latest trend..
GLAND5 months ago

Gland Pharma Limited (gland) Reports Record Revenues and Profitability Consolidated Q4 FY26: 22% Yoy Growth in Revenue and 97% PAT Growth

Gland Pharma Limited (NSE: GLAND) reports record revenues and profitability with 22% YoY growth in Q4 FY26 and 97% PAT growth.

More Posts